Lead-removing growth-assisting tablet and its preparing method

A vitamin and fully mixed technology, applied in the direction of pharmaceutical formula, medical preparations containing active ingredients, pill delivery, etc., can solve the problems of insufficient supply of vitamins, difficulty in achieving a balanced diet, etc., and achieve the effect of taking a small dose

Active Publication Date: 2006-08-09
ZHEJIANG ACAD OF MEDICAL SCI
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Some people believe that if the diet can be reasonably prepared, it can meet the needs of children for various vitamins, so there is no need for additional supplementation; It is difficult to achieve a balanced diet, which will more or less cause insufficient supply of certain vitamins. At the same tim

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0102] The various raw and auxiliary materials in the formula must meet the relevant standards before they are accepted. All raw materials are sieved through a 100-mesh sieve for later use. Vitamin B 1 0.2g, vitamin B 2 0.2g, vitamin B 6 0.2g, vitamin B 12 After fully mixing 0.5mg and 0.2g of selenate polysaccharide, add 2g of vitamin A and 10g of zinc lactate one by one, and fully mix one by one, then add 20g of vitamin C, 20g of ferrous gluconate, 20g of lysine, and 20g of taurine in two times Mix well, and finally add 200g of xylitol and 200g of calcium carbonate in three times, and stir thoroughly each time until the final mixing is even, and then use starch slurry as the binder to make granules, and heat the mixture at 55°C to 60°C Bake at high temperature to form dry granules, then use magnesium stearate as lubricant to compress into tablets.

Embodiment 2

[0104] The various raw and auxiliary materials in the formula must meet the relevant standards before they are accepted. All raw materials are sieved through a 100-mesh sieve for later use. Vitamin B 1 0.3g, Vitamin B 2 0.3g, vitamin B 6 0.3g, Vitamin B 12 After fully mixing 0.7mg and 0.30g of selenate polysaccharide, add 2g of vitamin A and 15g of zinc lactate one by one, and mix well one by one, then add 30g of vitamin C, 30g of ferrous gluconate, 30g of lysine, and 30g of taurine Mix well, and finally add 300g of xylitol and 300g of calcium carbonate in three times, and stir thoroughly each time until the final mixing is even, then use starch slurry as the binder to make granules, at 45 ℃ ~ 50 ℃ Vacuum dry at high temperature into dry granules, and then use magnesium stearate as lubricant to compress into tablets.

Embodiment 3

[0106] The various raw and auxiliary materials in the formula must meet the relevant standards before they can be accepted. All raw materials are sieved through 80 meshes for later use. Vitamin B 1 0.4g, vitamin B 2 0.4g, vitamin B 6 0.4g, vitamin B 12 0.6mg, 0.40g of selenate polysaccharides are fully mixed, then add 2.5g of vitamin A, 20g of zinc lactate one by one, and fully mix one by one, then add 40g of vitamin C, 40g of ferrous gluconate, 40g of lysine, taurine A mixture of 40g of acid, mixed thoroughly, and finally, the mixture of 400g of xylitol and 400g of calcium carbonate was added in three times, stirring fully each time until the final mixing was uniform, and then made into granules with starch slurry as the binder, at about 55°C Bake at high temperature to form dry granules, then use magnesium stearate as lubricant to compress into tablets.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to a health-care product, in particular, it relates to a lead-discharging growth-promoting tablet for preventing child growth retardation due to nutritional deficiency and higher blood lead content resulten from contaction with envriomental lead and its preparation method. Said lead-discharging growth-promoting tablet is made up by using vitarmin A, vitamin B1, vitamin B2, vitamin B6, vitamin C, vitamin B12, zinc lactate, calcium carbonate, selenate polysaccharide, ferrous gluronate, lysine, taurine and xylitol through a certain preparation process. Besides, said invention also provides the concrete steps of its preparation method.

Description

technical field [0001] The invention relates to a health food, in particular to a lead-expelling booster tablet for preventing children from growth retardation caused by lack of nutrition and high blood lead caused by exposure to environmental lead and a preparation method thereof. Background technique [0002] Growth retardation is a common nutritional deficiency disease. Its incidence is widespread all over the world, and it is more common in infants, children, and teenagers. For many years, people have been studying its etiology and prevention measures and discussing whether children need to supplement multivitamins. Some people believe that if the diet can be reasonably prepared, it can meet the needs of children for various vitamins, so there is no need for additional supplements; It is difficult to achieve a balanced diet, which will more or less cause insufficient supply of certain vitamins. At the same time, it is believed that the current r...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K33/10A61K31/714A61K31/715A61K31/07A61K31/375A61K31/525A61K31/4415A61K31/191A61K31/185A61K31/198A61K9/20A61P39/02A61P43/00
Inventor 王茵周淡宜徐水祥
Owner ZHEJIANG ACAD OF MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap